We are live on ! Find out more
KIA

Kopp Investment Advisors Portfolio holdings

AUM $54.4M
1-Year Est. Return 14.33%
This Fund
S&P 500
This Quarter Est. Return
+19.27%
1 Year Est. Return
+14.33%
3 Year Est. Return
+109.21%
5 Year Est. Return
+340.72%
10 Year Est. Return
–
AUM
$203M
AUM Growth
+$17.5M
Cap. Flow
-$7.87M
Cap. Flow %
-3.87%
Top 10 Hldgs %
66.21%
Holding
70
New
5
Increased
15
Reduced
33
Closed
4

Top Buys

Rank Stock Value
1
EMKR
Emcore Corp
EMKR
+$2.71M
2
XENT
Intersect ENT, Inc
XENT
+$2.36M
3
SPSC icon
SPS Commerce
SPSC
+$1.41M
4
VG
Vonage Holdings Corporation
VG
+$1.29M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$911K

Top Sells

Rank Stock Value
1
SUPN icon
Supernus Pharmaceuticals
SUPN
+$10.2M
2
FNSR
Finisar Corp
FNSR
+$3.08M
3
CTCT
CONSTANT CONTACT, INC COM
CTCT
+$2.13M
4
STKL
SunOpta
STKL
+$753K
5
OCLR
Oclaro Inc.
OCLR
+$689K

Sector Composition

Rank Sector Weight
1 Technology 48.99%
2 Healthcare 40.39%
3 Financials 1.76%
4 Industrials 1.61%
5 Miscellaneous 1.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OCLR
1
DELISTED
Oclaro Inc.
OCLR
$37.2M 18.28%
10,684,689
-220,540
-2% -$689K
EMKR
2
DELISTED
Emcore Corp
EMKR
$22.2M 10.93%
362,542
+39,070
+12% +$2.71M
TLGT
3
DELISTED
Teligent, Inc
TLGT
$17M 8.37%
191,355
-1,777
-0.9% -$142K
XENT
4
DELISTED
Intersect ENT, Inc
XENT
$12.6M 6.18%
558,339
+119,530
+27% +$2.36M
NEO icon
5
NeoGenomics
NEO
$2.39B
$12.3M 6.06%
1,567,526
+4,258
+0.3% +$31.2K
FNSR
6
DELISTED
Finisar Corp
FNSR
$9.63M 4.73%
661,929
-248,475
-27% -$3.08M
GIMO
7
DELISTED
Gigamon Inc.
GIMO
$7.56M 3.72%
284,695
+27,720
+11% +$712K
IL
8
DELISTED
IntraLinks Holdings Inc.
IL
$5.92M 2.91%
652,135
+26,575
+4% +$245K
SRGA
9
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$5.81M 2.86%
48,779
-2,205
-4% -$284K
ATRC icon
10
AtriCure
ATRC
$2.51B
$4.44M 2.18%
197,885
-4,150
-2% -$85.5K
IDTI
11
DELISTED
Integrated Device Technology I
IDTI
$3.97M 1.95%
150,700
-5,530
-4% -$142K
OMCL icon
12
Omnicell
OMCL
$1.52B
$3.9M 1.92%
125,417
+1,649
+1% +$48.7K
NXTM
13
DELISTED
NxStage Medical Inc.
NXTM
$3.72M 1.83%
169,612
+20,855
+14% +$389K
AKRX
14
DELISTED
Akorn Inc
AKRX
$3.48M 1.71%
93,280
-1,570
-2% -$49.1K
LGND icon
15
Ligand Pharmaceuticals
LGND
$5.67B
$3.31M 1.63%
48,875
-1,632
-3% -$101K
CEMP
16
DELISTED
Cempra, Inc.
CEMP
$2.76M 1.36%
88,656
-6,465
-7% -$180K
RKUS
17
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
$2.72M 1.34%
253,735
-7,693
-3% -$89.4K
PODD icon
18
Insulet
PODD
$9.95B
$2.71M 1.33%
71,611
-830
-1% -$27.9K
ENZ
19
DELISTED
Enzo Biochem, Inc.
ENZ
$2.66M 1.31%
590,874
-79,153
-12% -$334K
SWKS icon
20
Skyworks Solutions
SWKS
$10.1B
$2.44M 1.2%
31,719
-507
-2% -$40.6K
KTWO
21
DELISTED
K2M Group Holdings, Inc
KTWO
$2.01M 0.99%
101,880
-471
-0.5% -$9.15K
VG
22
DELISTED
Vonage Holdings Corporation
VG
$1.96M 0.96%
341,595
+207,540
+155% +$1.29M
QRVO icon
23
Qorvo
QRVO
$8.49B
$1.9M 0.94%
37,396
-95
-0.3% -$4.86K
ARRY
24
DELISTED
Array Biopharma Inc
ARRY
$1.59M 0.78%
376,477
-5,300
-1% -$24.2K
CVLT icon
25
Commault Systems
CVLT
$5.82B
$1.56M 0.77%
39,716
+7,680
+24% +$300K
1
2 3

Similar funds

OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
GX
Greylock XII Menlo Park, California $51.9M AUM 11.52% 1-Year Est. Return
PGA
Premia Global Advisors Coral Gables, Florida $57.9M AUM 2.91% 1-Year Est. Return
SCG
Saban Capital Group Los Angeles, California $59.5M AUM 3.83% 1-Year Est. Return
TCMV
Technology Crossover Management VI Menlo Park, California $59.6M AUM 18.81% 1-Year Est. Return
FCM
Farmstead Capital Management Ridgewood, New Jersey $49M AUM 10.57% 1-Year Est. Return
SAM
Sheffield Asset Management Chicago, Illinois $48.1M AUM 12.96% 1-Year Est. Return
ACP
Aquiline Capital Partners New York $46.9M AUM 5.65% 1-Year Est. Return

Kopp Investment Advisors's Q4 2015 Portfolio in Review

As of Q4 2015, Kopp Investment Advisors held 70 positions worth $203M, up 9.4% from $186M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Kopp Investment Advisors withdrew a net $7.87M in Q4 2015, closing 4 positions and reducing 33 holdings. Its most notable exit was Supernus Pharmaceuticals, an estimated $10.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 49% of assets, up from 45% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Kopp Investment Advisors opened a new position in SPS Commerce worth $1.35M.

  • Kopp Investment Advisors's largest Q4 2015 buy was SPS Commerce: 38,528 shares worth $1.35M.
  • Kopp Investment Advisors added most to Emcore Corp in Q4 2015, an estimated $2.71M increase.
  • Kopp Investment Advisors's biggest Q4 2015 reduction was Finisar Corp, cutting an estimated $3.08M.
  • Kopp Investment Advisors fully exited Supernus Pharmaceuticals in Q4 2015, selling an estimated $10.2M.
  • Kopp Investment Advisors's ten largest holdings make up 66% of its $203M portfolio in Q4 2015.
  • Kopp Investment Advisors opened 5 new positions and closed 4 in Q4 2015.
  • Kopp Investment Advisors's portfolio value rose 9.4% quarter-over-quarter to $203M.

Based on Kopp Investment Advisors's 13F filing for Q4 2015, filed 16 Feb 2016.